Ergonomics in apiculture: A case study based on inspecting movable frame hives for healthy bee activities.

The agricultural sector suffers from high risk of injury and damage to human health. There is considerable research not only identifying these risks but also finding ways to mitigate them. Beekeeping or apiculture, recognised as part of this sector, has many risk factors such as heavy lifting, high degree of manual materials handling, twisting, and awkward positioning common to all agriculture areas. It also has some unique risks such as those resulting from bee stings and smokers. However, there is much less attention focused on the health and safety of apiculture to the human beekeepers, and much more attention focused on bee health and safety. An ergonomics case study on beekeeping inspection tasks involving three independent, local beekeepers showed that many tasks involve awkward positions of the body, arms and hands, excessive lifting well beyond recommended weight limits, eye strain, and chemical and sting exposure. In addition, beekeepers are more interested in bee and hive health rather than reducing human-centred risk factors such as those due to excessive lifting. Standard ergonomics interventions such as a magnifier inspection and lift assist systems as well as interventions unique to beekeeping such as a smokeless method of calming bees are recommended. The beekeeping industry seems to have been forgotten in the modernisation of technology and agricultural practices. This paper offers some initial insights into possible points for research, development and improvements.

Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment.

Background: A wide range of response rates have been reported in HER2-positive gastric cancer (GC) patients treated with trastuzumab. Other HER2-targeted therapies for GC have yet to show efficacy in clinical trials. These findings raise question about the ability of standard HER2 diagnostics to accurately distinguish between GC patients who would and would not benefit from anti-HER2 therapies. Patients and methods: GC patients (n = 237), including a subset from the Trastuzumab in GC (ToGA) trial were divided into three groups based on HER2 status and history of treatment with standard chemotherapy or chemotherapy plus trastuzumab. We applied mass spectrometry-based proteomic analysis to quantify HER2 protein expression in formalin-fixed tumor samples. Using HER2 expression as a continuous variable, we defined a predictive protein level cutoff to identify which patients would benefit from trastuzumab. We compared quantitated protein level with clinical outcome and HER2 status as determined by conventional HER2 diagnostics. Results: Quantitative proteomics detected a 115-fold range of HER2 protein expression among patients diagnosed as HER2 positive by standard methods. A protein level of 1825 amol/µg was predicted to determine benefit from the addition of trastuzumab to chemotherapy. Trastuzumab treated patients with HER2 protein levels above this cutoff had twice the median overall survival (OS) of their counterparts below the cutoff (35.0 versus 17.5 months, P = 0.011). Conversely, trastuzumab-treated patients with HER2 levels below the cutoff had outcomes similar to HER2-positive patients treated with chemotherapy. (Progression-free survival = 7.0 versus 6.5 months: P = 0.504; OS = 17.5 versus 12.6 months: P = 0.520). HER2 levels were not prognostic for response to chemotherapy. Conclusions: Proteomic analysis of HER2 expression demonstrated a quantitative cutoff that improves selection of GC patients for trastuzumab as compared with current diagnostic methods.

Proteomic analysis of nuclei dissected from fixed rat brain tissue using expression microdissection.

Expression microdissection (xMD) is a high-throughput, operator-independent technology that enables the procurement of specific cell populations from tissue specimens. In this method, histological sections are first stained for cellular markers via either chemical or immuno-guided methods, placed in close contact with an ethylene vinyl acetate (EVA) film, and exposed to a light source. The focal, transient heating of the stained cells or subcellular structures melts the EVA film selectively to the targets for procurement. In this report, we introduce a custom-designed flashcube system that permits consistent and reproducible microdissection of nuclei across an FFPE rat brain tissue section in milliseconds. In addition, we present a method to efficiently recover and combine captured proteins from multiple xMD films. Both light and scanning electron microscopy demonstrated captured nuclear structures. Shotgun proteomic analysis of the samples showed a significant enrichment in nuclear localized proteins, with an average 25% of recovered proteins localized to the nucleus, versus 15% for whole tissue controls (p < 0.001). Targeted mass spectrometry using multiple reaction monitoring (MRM) showed more impressive data, with a 3-fold enrichment in histones, and a concurrent depletion of proteins localized to the cytoplasm, cytoskeleton, and mitochondria. These data demonstrate that the flashcube-xMD technology is applicable to the proteomic study of a broad range of targets in molecular pathology.

Mechanical ventilation of critically ill newborns on scheduled flights of commercial passenger aircraft.

Transport of critically sick neonates of any gestation on scheduled commercial passenger aircraft is practical, safe, and cost effective. There is no disruption to boarding or egress of passengers and no seats need be removed or rearranged. Civil Aviation and Federal Aviation Authority regulations are obeyed. Power supply modifications and strengthening of the transport incubator are necessary. Other standard neonatal intensive care equipment can be used in battery mode. Replacement of an endotracheal tube in-flight is not difficult.

Developmental and ploidy characteristics of "senescent" unfertilized eggs of Xenopus laevis.

Unfertilized eggs of Xenopus laevis have been stored in a high salt physiological saline (De Boer's solution) over a period of about 24 hours. During this time, aliquots have been subjected to lowered salinity and fertilized. The stored eggs undergo a defined series of morphological changes, which are initially reversible upon fertilization. Length of storage may have little or no effect on the capacity of the eggs to undergo cleavage, but the normal developmental capacity declines with increasing storage time. Among the characteristics of this decline is a regressive cytokinesis, early arrest, and the appearance in surviving larvae of a definable syndrome of morphological type. Increasing storage times predispose the eggs to subsequent triploid development, the triploidy arising as a consequence of failure of second polar body emission. The possible interest of these findings for a model system of mammalian gamete aging is discussed.

The response of the brachial ventral horn or Xenopus laevis to forelimb amputation during development.

The normal development of the brachial ventral horn of the frog Xenopus laevis and the response of the brachial ventral horn to complete forelimb extirpation at five developmental stages were assessed histologically. Differentiation of brachial ventral horn neurons occurred in pre-metamorphic tadpoles between stages 52/53 and 57. Mean cell number in the brachial ventral horn reached a peak of 2576 (S.E.M. equals +/- 269, N equals 2) per side of the spinal cord at stage 55 and decreased to 1070 (S.E.M. equals +/- 35, n equals 7) by the end of metamorphosis. Cell degeneration was presumed to be the mode of cell loss since it was most prevalent during the period of rapid decrease in cell numbers. The response of the ventral horn to forelimb removal varied with the stage of the animal at amputation. Following amputation at stage 52/53 or 54 the ipsilateral ventral horn neurons appeared less differentiated than those on the control side and a rapid cell loss of about 80% occurred on the operated side. These effects occurred more rapidly after ablation at stage 54 than at stage 52/53. Amputation at stage 58, 61, or 66 caused chromatolysis in the ventral horn, a period of relative cell excess on the operated side, and a delayed neuronal loss of 32-66%. It was concluded that excess cell degeneration accounted for cell loss and that suppression of normal neuronal degeneration caused the relative cell excess on the operated side. The data indicate that the brachial ventral horn was indifferent to the periphery before stage 54, was quickly affected by limb removal between stages 54 and 58, and by stage 58 had entered a phase in which a delay preceded cell death. No forelimb regeneration occurred.